How 3 dental technology companies performed in Q3

Here is how Align Technology, Biolase and Sonendo performed during the third quarter of 2023: 

Align Technology

• Total revenue was $960.2 million.
• Operating income was $166.3 million.
• The company had more than $1.3 billion in cash, cash equivalents and short-term and long-term marketable securities as of Sept. 30.

Biolase

• Total revenue was $10.9 million.
• Total consumable sales were $2.9 million.
• Total operating expenses were $7.4 million.
• The company had cash and cash equivalents of approximately $7.8 million.

Sonendo

• Total revenue was $10.4 million.
• Total operating expenses were $18.5 million.
• Net loss was $17 million.
• The company had $55.9 million in cash and cash equivalents and short-term investments.